New Breast Cancer Research

By: Courtney Lassiter
By: Courtney Lassiter

For the first time older women at high risk may soon have a choice of preventive medicine to battle breast cancer.
A new study shows the drug Raloxifene ,which is used to treat Osteoporosis, can prevent breast cancer and with fewer side effects than Tamoxifen, the only drug approved to prevent breast cancer.
"It's still preventing people from having to go through surgeries, chemo and radiation."
Judy Rondeau faces 7 more rounds of chemotherapy treatments since she's younger than 40 and pre-menopause.
"And here, it's a big shock I'm having this."
But now, her 6 older sisters can take Raloxifene to prevent breast cancer.
"Any risk that can be eliminated from a single woman is the best gift any woman can receive as far as I'm concerned."
She's taken a gene test to see if her daughter will be prone to breast cancer.
"I think I got this as means of educating myself it's also going to prevent one other person from getting it."
Like her daughter, who at four-years-old takes care of Mommy sometimes.
"She is a huge helper, she says Momma, I know you need to sit, you're tired, I will go swing or let's have juice together."
She knows she's her mother's reason for fighting and by battling breast cancer women like Judy Rondeau may be saving her life one day.
"That's all you need, to save one person, then it turns into 3,4, 5."
The study involved almost 20,000 post-menopausal women at high risk for breast cancer, including women 60 or older who had frequent biopsies or had family members with breast cancer.
The study proved women taking Raloxifene cut their risk of breast cancer by 50% and had fewer side effects like no increase in uterine cancer, fewer life threatening blood clots and fewer cataracts.


WBKO 2727 Russellville Road Bowling Green, KY 42101-3976 Phone: 270-781-1313 After Hours Hotline: 270-781-6397 Fax: 270-781-1814
Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 2653271 - wbko.com/a?a=2653271
Gray Television, Inc.